VALRUBICIN

Manufacturer:

LEUCADIA PHARMACEUTICALS

Name:

VALRUBICIN

HCPCS Code Descriptor:

Injection, valrubicin, intravesical, 200 mg

Category:

J Code

HCPCS:

J9357

NDC(s):

67979-0001-01, 24201-0101-04

Primary Type:

Oncology

Generic Status:

Multi-Source

Route of Administration:

Urinary bladder

About:

VALRUBICIN is a Oncology drug manufactured by LEUCADIA PHARMACEUTICALS and administered via the Urinary bladder route of administration. The J Code: J9357 is aligned to the drug VALRUBICIN.

VALRUBICIN is an anticancer medication that belongs to the class of drugs known as anthracyclines. This medication works by slowing down and stopping the growth of cancer cells. VALRUBICIN is often used to treat certain types of bladder cancer. This drug is manufactured by Endo pharmaceuticals, Valera incorporated, and Leucadia pharmaceuticals. VALRUBICIN is aligned to the HCPCS code J9357 and has been since January 2009.